CoEHAR Replica study: “Claim that e-cigarette aerosols make cancer cells more resistant to chemotherapy debunked!”

Post author:daniela
Post published:24 April 2026
Post category:Press Release Replica

A multicenter replication study conducted by CoEHAR researchers, under the Replica project, reports no consistent evidence that e-cigarette aerosols reduce chemotherapy sensitivity in laboratory models of head and neck cancer.…

Hereditary cancer and genetic background, CoEHAR at the Temple University

Post author:Chiara Nobis
Post published:15 May 2023
Post category:Press Release Replica

"From biologic mechanisms to theragnostic paths in the Hereditary Cancer Syndromes: germline mutations as a therapeutic target" is the title of the meeting held at the Temple University, Friday, May 12. Although hereditary cancer…

CoEHAR among the contributors of the Beating Cancer Plan

Post author:Chiara Nobis
Post published:28 April 2021
Post category:Press Release

The Center of Excellence for the Acceleration of Harm Reduction (CoEHAR) is among the contributors for the drafting of the BECA Report by the Special Committee on Cancer of the European Parliament